Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
About Us
- Home
- About Us
About Dosage Life Sciences
Dosage Life Sciences (P) Limited (DLS) – At a Glance
Dosage Life Sciences (P) Limited (DLS) is a trusted consultancy and manufacturing partner specializing in the pharmaceuticals, nutraceuticals, and cosmeceuticals sectors.
We offer end-to-end solutions across Greenfield/Brownfield project execution, formulation development, regulatory compliance, and contract manufacturing, empowering clients to achieve excellence in both regulated and emerging markets.
Led by industry veteran Dr. Rajesh K. Singh, who brings over 30 years of leadership experience from top pharmaceutical companies, our expert team covers all critical domains, including Quality Assurance (QA), Regulatory Affairs (RA), sterile and non-sterile manufacturing, and process engineering.
At DLS, we deliver comprehensive support encompassing R&D, regulatory submission, and commercial launch across a wide range of dosage forms, API processing, sterilization technologies, and global CDMO projects.
More About Dosage Life Sciences
DLS is a dynamic, knowledge-driven Contract Research and Development Organization (CRDO) and Contract Manufacturing and Distribution Organization (CDMO) dedicated to advancing pharmaceutical innovation through a comprehensive suite of formulation development, analytical solutions, and cutting-edge manufacturing capabilities. We serve pharmaceutical manufacturing companies worldwide with a strong focus on quality, compliance, stable, safe, and effective drug products, as well as customer-centric innovation.
Our foundation is built upon decades of expertise through strategic partnerships and deep-rooted experience in pharmaceutical sciences, sophisticated instrumentation, and regulatory excellence. With state-of-the-art facilities certified by WHO-GMP, ISO 9001, and DSIR, DLS integrates science, technology, and a passion for innovation to deliver tailored solutions across the drug development lifecycle—from preclinical research to commercial manufacturing.
Our capabilities encompass a comprehensive range of services, including:
- Formulation Development: Expertise in oral solids, liquids, topical, nasal sprays, parenteral, Dry powder inhaler, pMDI and soft gelatine capsules and Effervescent powder and tablets.
- Analytical Development: Extensive analytical support emphasizing regulatory compliance and data integrity.
- Contract Manufacturing: High-quality production of potent and non-potent pharmaceutical formulations inspected and approved by LFDA and WHO etc. agencies.
- Technology Transfer & IP Support: Efficient transfer of technology with robust intellectual property protection and guidance on global regulatory strategies.
- Our experienced teams of Engineers, scientists and regulatory experts are dedicated to delivering high-performance, scalable, and regulatory-compliant drug products. With a presence in key geographies and a profound understanding of industry trends, DLS is uniquely positioned to be your trusted partner in pharmaceutical innovation.
- At DLS, we do not simply deliver services—we cultivate partnerships. Our philosophy is founded on Trust, Transparency, and Scientific Excellence, with the unwavering goal of creating a better tomorrow through impactful healthcare solutions.
Leadership With Vision:
Promoter, Managing Director, and Chief Scientific Officer (CSO) Dosage Life Sciences Private Limited (DLS)
— Dr. Rajesh K. Singh, CSO & Managing Director, DLS
At the heart of Dosage Life Sciences Private Limited (DLS) is Dr. Rajesh K. Singh, a distinguished pharmaceutical leader with over the three decades of experience in steering Projects, innovation, strategy, and regulatory excellence across global markets.
Over the span of his career, Dr. Singh has held senior leadership positions at prominent pharmaceutical giants such as Ranbaxy Laboratories Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, and Morepen Laboratories Limited. In these roles, he successfully led multidisciplinary teams in the Operation, Projects (Green/Brown field), Infrastructure and process development, regulatory submission, and launch of over various drug products across domestic, regulated , semi-regulated & ROW markets.
Key Achievements:
- Led the development of first-to-file generics and innovative fixed-dose combinations.
- Played a pivotal role in securing timely regulatory filings and approvals for major therapeutic launches.
- Honoured with prestigious industry awards from previous organisations such as Ranbaxy, Glenmark including:
- Exceptional commitment Award
- Best Team Innovation Award
- Operational Excellence in Product Lifecycle Management and so on..
Dr. Singh is highly regarded in the industry for his deep knowledge in Product/Process engineering, regulatory expertise, agile decision-making and unwavering commitment to quality and innovation.
A Vision for the Future
Under his leadership, DLS is set to become a Centre of Excellence in pharmaceutical consultancy, drug product and substance development, and ethical marketing. The company is committed to building a portfolio that reflects world-class standards, scientific precision, and customer-centric service and word class quality products in various segments.
“At DLS, we aim to bridge science with purpose — by developing high-quality, accessible pharmaceuticals and delivering them through trust, speed, and innovation.”
Our Vision
To become a leading and trusted name in the pharmaceutical industry by delivering innovative, affordable, and high-quality healthcare solutions that improve lives across the globe.
Our Mission
Our mission is to provide superior-quality medicines and services through continuous innovation, ethical business practices, and a strong commitment to customer satisfaction. We strive to build lasting partnerships and empower entrepreneurs through the best franchise opportunities and healthcare solutions.
Best Medical & Healthcare
Trust Us To Be There To Help All & Make Things Well Again
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
Our Team
Meet With Our Expertise
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
The Journey
Our flagship Exclusive Network companies
1. Theon Pharmaceuticals Ltd. and Theon Lifesciences Ltd. – Our most preferred development partners, where the Chief Scientific Officer (CSO) is personally involved in day-to-day R&D activities.
2. Mint Lifesciences Pvt. Ltd., Mint Cosmeceuticals Pvt. Ltd., and Mint Nutraceuticals Pvt. Ltd. – Trusted strategic partners across pharmaceutical, cosmeceutical, and nutraceutical domains.
3. Bharat Sterile Pvt. Ltd. – Engaged in Greenfield project consultancy and infrastructure development.
4. Bioaltus Pvt. Ltd., Mumbai – Collaborating on advanced pharmaceutical innovations.
5. Krishiv Bioscience Pvt. Ltd., Kolkata – A key partner in biotech and formulation development and Greenfield infrastructure development for manufacturing of various dosage forms.
6. Asthabandhu Agri India Pvt. Ltd., Kushinagar, Uttar Pradesh – Veterinary healthcare division partner.
Our Comprehensive Pharma Products & Services Portfolio Offerings
DLS is set to emerge as a trusted name in the Indian and global pharmaceutical landscape, offering a robust portfolio of high-quality drug products, drug substances (APIs), and integrated marketing solutions. Backed by scientific expertise, regulatory know-how, and customer-centric innovation, our upcoming product range reflects our commitment to improving healthcare access and outcomes.
1. Finished Dosage Forms (FDFs) – Drug Products
Our formulation portfolio will focus on high-demand therapeutic areas with a mix of generic and differentiated formulations. DLS’s product development will follow a science-driven, patient-centric approach, with a focus on bioavailability, stability, and regulatory compliance.
💊 Planned Product Categories
| Tablets – IR, ER, MR, ODTs |
| Capsules – Hard gelatine, Soft gelatine |
| Oral Liquids and Suspensions |
| Topical Preparations – Creams, Ointments, Gels |
| Injectables – Small volume parenteral (SVPs), Lyophilized vials |
| Sachets and Powders |
| Novel Drug Delivery Systems (NDDS) – Under development |
🎯 Target Therapeutic Segments
| Cardiovascular |
| Anti-Diabetic |
| Anti-Infective |
| Pain Management |
| Gastrointestinal |
| Dermatology |
| Respiratory |
| Neurology & Psychiatry |
| Vitamins & Nutraceuticals |
2. Active Pharmaceutical Ingredients (APIs) – Drug Substances
DLS plans to manufacture and supply high-quality, regulatory-compliant APIs for domestic and global markets. Our API operations will focus on sustainable chemistry, scalability, and regulatory excellence.
⚗️ API Product Focus
| Generic APIs aligned with key FDFs |
| Niche APIs with complex synthesis pathways |
| High-Potency APIs (HPAPIs) – Phase 2 |
| Intermediates and Custom Synthesis |
💼 API Business Strengths
| In-house R&D-driven process development |
| Strong backward integration strategy |
| DMF preparation for global filings |
| Quality assurance in line with cGMP standards |
3. Marketing & Distribution (India Focus)
DLS aims to build a strong domestic presence through strategic marketing, ethical promotion, and robust channel partnerships. Our goal is to bridge quality pharma with market needs across urban and semi-urban India.
🏢 Key Business Verticals
| Branded Generics – Promoted through medical representatives and specialty divisions |
| Institutional Business – Government tenders and hospital supplies |
| Trade Generics – PAN India distribution via stockists and retailers |
| Digital Healthcare Channels – E-commerce and telehealth platforms (Phase 2) |
📈 Marketing Strategy
| Therapeutic segment-focused divisions |
| Scientific-based promotional content |
| Continuous doctor engagement programs |
| Regional distribution networks with optimized logistics |
4. Contract Development and Manufacturing (CDMO) – Future Service
As DLS expands, we plan to offer end-to-end CDMO services for global clients seeking a reliable partner in India for formulation development, scale-up, and commercial manufacturing.
🔬 Future CDMO Capabilities
| Formulation development and tech transfer |
| API contract manufacturing |
| Dossier development and regulatory support |
| Technology transfer and lifecycle management |
Call Us and Give Order
Contact Us and Become a Partner.
+91-9215226306
Our Blog
Lates News & Articles
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod enim tempor incididunt ut labore et dolore magna aliqua